022615-small

Avastin, Eylea, or Lucentis – which best for diabetic macular edema?

A recent study did a comparison of the three top drugs used to treat diabetic macular edema. Researchers took a look at Avastin, Eylea and Lucentis and while all three drugs were equally effective in improving vision in patients who had slight vision impairment, Eylea was found to be more effective in treating patients with […]

022415

Wink-controlled contact lenses created to treat macular degeneration

The prototype of wink-controlled contact lenses was unveiled at the American Association for the Advancement of Science’s annual meeting recently. This most recent prototype is an improvement upon a model introduced back in 2013. The new version comes with smart glasses and a tiny reflective telescope that is activated by a wink of the eye. […]

021915

Lucentis gains FDA approval for treating diabetic retinopathy

Earlier this month, the FDA expanded the approved use of Lucentis to include its use in treating diabetic retinopathy in people who have diabetic macular edema. The announcement came after two clinical studies confirmed the drug’s safety and efficacy in treating diabetic retinopathy in diabetic macular edema patients. Patients involved in the study who received […]

Sight for Life Photo Contest

Sight for Life Photo Contest

Now through March 31, 2015, enter Dr. Krawitz’s Sight for Life Photo Contest! Click The Image Below:

021715_1

Did macular degeneration play a role in release of Harper Lee’s new novel?

Controversy has swirled around the recent announcement that the sequel to Harper Lee’s American classic, To Kill a Mockingbird will be published. Whether or not publishing Go Set a Watchman was Lee’s decision or not is the big question. Mired within all of the details surrounding the book’s release is the question of Harper Lee’s […]

021215

Does cost go into macular degeneration prescription decisions?

When it comes to treating the wet form of macular degeneration, there are two drugs that doctors typically consider and while the drugs are equally effective, the cost of each is dramatically different. Researchers decided to examine whether the cost difference between these two had significant bearing upon which drug a doctor prescribed. Ranibizumab was […]

2014-visivite-customer-favorites

VisiVite Gold Formula was Customer Favorite in 2014

VisiVite offers consumers and eye doctors the widest selection of supplements for macular health and dry eye. And yet, the competition for VisiVite’s favorite formula wasn’t a close race in 2014. By a wide margin, customers chose the flagship product, VisiVite AREDS2 PLUS+ Gold Formula for exceeding the minimum recommendations, the high quality natural ingredients, and its fast-absorbing […]

deep breath

Deep Breathing may help Dry Eyes

An article in The Ocular Surface outlines details of research conducted at the Keio University School of Medicine in Tokyo, Japan. The study involved twenty Japanese women ranging in age from 20 to 54 and examined the effects that deep breathing had on tear secretions. Knowing that the parasympathetic system directs the lacrimal glands to […]

020515

Positive results for early macular degeneration with laser therapy

University of Melbourne researchers published the results of their latest study in The FASEB Journal. This study evaluated the effectiveness of the new nanosecond laser in treating patients with early age-related macular degeneration. This revolutionary laser is low-impact and low-energy. What researchers found is that unlike current laser therapies,  the nanosecond laser does not damage […]

020315-small

New therapies to treat blindness and stroke could be tied within gene interactions

VisiVite offers a combination of its formulas with DHA omega-3, and here are additional reasons why that combination is effective. Researchers at LSU Health New Orleans have found that gene interactions that deal with vision as well as brain function can help prevent blindness and aid in stroke recovery. The essential fatty acid, DHA, is […]